期刊文献+

基于网络药理学研究茶枯提取物的抗血栓作用机制 被引量:1

Study on Antithrombotic Mechanisms of Camellia Cake Extracts by Network Pharmacology
下载PDF
导出
摘要 目的:基于网络药理学研究茶枯提取物的抗血栓作用机制。方法:选择茶枯提取物中16个活性成分,通过Pharm Mapper网络平台预测潜在靶点,通过Gene cards及OMIM网络平台检索血栓相关基因,将两者交集获取茶枯提取物活性成分抗血栓靶点,进而构建PPI网络、活性成分-交集基因-疾病网络,对GO及KEGG通路进行富集分析。结果:共交集得到91个茶枯提取物活性成分抗血栓靶点,主要涉及AKR1B1、MME、CASP3、F2和HSP90AA1。83个GO条目全部涉及分子功能。99条KEGG通路中P值最显著的前5个依次为:流体剪切应力与动脉粥样硬化、催乳素信号途径、百日咳、胰岛素抵抗及补体及凝血级联反应。结论:茶枯提取物抗血栓作用机制涉及多种成分及多个靶点。 Objective:To study the antithrombotic mechanisms of Camellia cake extracts by network pharmacology.Methods:16 active ingredients were selected from in Camellia cake extracts,potential targets were predicted by Pharm Mapper,search thrombus-related genes were searched from through Gene cards and OMIM,then intersection targets were obtained,PPI network,active ingredient-intersection gene-disease network were constructed,enrichment analysis of GO and KEGG pathway was performed.Results:91 antithrombotic targets of active ingredients were obtained,which were mainly involved with AKR1B1,MME,CASP3,F2,and HSP90AA1.All 83 GO entries were related to molecular functions.The top 5 KEGG pathways with most significant p-values were:fluid shear stress and atherosclerosis,prolactin signaling pathway,pertussis,insulin resistance,and complement and coagulation cascades.Conclusions:The antithrombotic mechanisms of Camellia cake extracts might involve multiple components and multiple targets.
作者 李林福 邱雨美 朱恒骞 崔海静 刘志平 张蕊 LI Lin-fu;QIU Yu-mei;ZHU Heng-qian;CUI Hai-jing;LIU Zhi-ping;ZHANG Rui(Gannan Medical University,Pharmacy College,Ganzhou,Jiangxi 341000;Gannan Medical University,School of Basic Medicine,Ganzhou,Jiangxi 341000)
出处 《赣南医学院学报》 2020年第4期386-391,共6页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
基金 国家自然科学基金项目(81660371,81860388) 赣南油茶产业开发协同创新中心开放基金项目(YK201607)。
关键词 茶枯提取物 网络药理学 抗血栓 作用机制 Camellia cake extracts network pharmacology antithrombosis mechanisms
  • 相关文献

参考文献10

二级参考文献63

  • 1廖书娟,童华荣,吉当玲.茶籽饼茶皂素提取及应用研究[J].粮食与油脂,2005,18(1):13-15. 被引量:42
  • 2李小飞,袁玲,文志斌.炎症与血栓形成的研究进展[J].国外医学(输血及血液学分册),2005,28(5):417-420. 被引量:13
  • 3梁雨祥.试谈我国油茶和优质山茶油的产业化开发[J].宏观经济研究,2006(1):25-27. 被引量:55
  • 4Sudano I, Spieker LE, Hermann F, et al. Protection of endothelial function: targets for nutritional and pharmacological interventions. J Cardiovasc Pharmaco1,2006,47 ( 2 ) : S136 - S150.
  • 5Somanath PR, Razorenova OV, Ghen J, et al. Aktl in endothelial cell and angiogenesis. Cell Cycle, 2006,5 ( 5 ) : 512 - 518.
  • 6Viniegra JG, Martinez N, Modirassari P, et al. Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM. J Biol Chem,2005,280(6) :4029 -4036.
  • 7Dugani CB, Klip A. Glucose transporter 4: cycling, compartments and controversies. EMBO Rep,2005,6 (12) : 1137 - 1142.
  • 8Sarbassov DD, Guertin DA, Ali SM, et al. Phosphorylation and regulation of Akt/PKB by the rictor- roTOR complex. Science,2005,307 (5712) :1098 - 1101.
  • 9Ohashi H, Takagi H, Oh H, et al. Phosphatidylinositol 3 - kinase/ Akt regulates angiotensin II - induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase - 3 activity. Circ Res,2004,94 (6) :785 - 793.
  • 10Amaravadi R, Thompson CB. The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest, 2005,115 (10) :2618 - 2624.

共引文献79

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部